For many enterprises, there continue to be barriers to fully adopting and benefiting from agentic AI. IBM is betting the blocker isn't building AI agents but governing them in production. At its ...

54 shot, 7 dead, in Chicago amid Trump's threat to deploy National Guard Bruce Willis’s wife hits back at criticism after moving Die Hard star into home Donald Trump's approval rating changes with low ...

Getting into competitive programming can feel like a lot at first. You’re trying to solve problems, make your code run fast, and not use too much memory. It’s a bit like a sport. But with tools like ...

Manage all AI prompts from one structured library with WinBuzzer Prompt Station. Use prompt-chains, prompts, text insertions with ChatGPT, Gemini, Claude, Grok, AI Studio, Mistral. With versioning, ...

A vulnerability that researchers call CurXecute is present in almost all versions of the AI-powered code editor Cursor, and can be exploited to execute remote code with developer privileges. The ...

Overview AWS's Kiro IDE uses an agent-powered workflow to iteratively transform user prompts into working code with test suites. Watch a hands-on demo of Kiro, as we take a simple prompt and make a ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

A Venn diagram from Amazon explains what it’s aiming for with its new Kiro software development tool. A new AI coding tool from Amazon uses agents to automatically create and update project plans and ...

MASSENA -- The Massena Public Library continues to be a popular attraction, with nearly 6,000 visitors during the month of May. According to Library Director Krista Briggs, the library saw 5,837 ...

Have you ever found yourself staring at a sluggish AI coding assistant, waiting for it to process tasks that should take seconds, not minutes? For developers relying on Cursor AI, Windsurf or other ...

Abbott Laboratories emphatically let Boston Scientific and Johnson & Johnson know it wanted a piece of the intravascular lithotripsy (IVL) space. The Abbott Park, IL-based company reported FDA had ...